Navigating Remote Blood Pressure Monitoring
Antoinette M. Schoenthaler,Safiya Richardson,Devin Mann
DOI: https://doi.org/10.1001/jamanetworkopen.2024.13739
2024-06-05
JAMA Network Open
Abstract:The 2023 joint American Heart Association and American Medical Association statement highlighted the proven impact of remote patient monitoring (RPM) on blood pressure (BP) control and underscored the need for widespread implementation of RPM in practice-based settings. 1 The article by Mehta et al 2 sought to fill this implementation gap by conducting a 3-arm randomized clinical trial comparing the effectiveness of RPM of BP and medication adherence reminders, RPM of BP and medication adherence reminders with feedback to a social support partner, and usual care on reduction of systolic BP at 4 months (primary outcome). The trial included 246 adults with uncontrolled hypertension at baseline. Participants in both the RPM alone and RPM plus support person groups received a free home BP monitor, 3 text message reminders per week to take and submit their BP readings, and 1 text message to assess their medication adherence over the past week. Patients in both arms also received weekly feedback on their BP and adherence data. Support partners who opted in to the study also received weekly feedback, which was used to send the partnered patient a weekly motivational message tailored to their BP and adherence data. The intervention arms also included a summary of the BP values and recommendations for medication adjustments sent to the primary care physician (PCP) via the electronic health record (EHR) to prompt medication titrations if 3 of the 10 BP readings were elevated based on Eighth Joint National Committee guidelines. For the cohort enrolled in 2018 (151 participants), the PCP-facing intervention components were sent to the PCP directly. For the second cohort in 2019 (100 participants), the PCP-facing intervention was redesigned to send the EHR messages to a centralized nurse who then routed medication changes to the PCPs. Patients randomized to the control arm received standard care. Overall, the investigators found no significant differences between the intervention and control groups for any of the BP outcomes. These negative findings need to be evaluated within the context in which the intervention was delivered and the choices made for the intervention content. Before discussing the limitations, it is important to point out some of the study's strengths. First, it was conducted at an urban primary care clinic and included mainly female and Black participants. Second, the provision of a free BP monitor, the use of text messages as a ubiquitous digital platform with high reach, and the inclusion of a support partner all help to address the digital determinants of health that limit health disparity populations' engagement with digital health interventions. 3 Finally, the intervention was well-received and highly recommended to others who may need it. Outside of these strengths, the study had several major shortcomings related to the implementation context and intervention choices that could explain the null results. First, regarding the implementation context, this study was conducted prior to the rapid expansion of RPM technologies to support virtual health care delivery, partly driven by the COVID-19 pandemic in 2020. In the first phase, the investigators relied on PCPs to review, interpret, and integrate the self-measured BP values into their treatment decisions. It is not surprising that PCPs had a low uptake of RPM. For PCPs, managing RPM data requires added work outside of routine clinical encounters (ie, new workflow) or added burden during clinical encounters, which disrupts their routine workflow. Task shifting, involved in reviewing RPM data through faxed paperwork, clicking on various parts of the EHR, or logging on to a third-party technology platform, is known to add cognitive burden and contribute to clinician burnout. While the study included social norm nudges to prompt PCP medication adjustments, the context matters here as well. Although social norm messaging has been shown to influence behavior, effects may have been minimized in this trial due to the larger context in which clinicians are now overburdened by reminders and messages. For this reason, we and others have shown that team-based care models that delegate RPM implementation to nonphysician practitioners, such as nurses or clinical pharmacists, is essential to effective clinical integration of RPM. 4 In the second phase, the investigators used a nurse-led model to implement the RPM program, but it did not improve the success of the intervention. This lack of improvement is difficult to explain without additional data. For example, how well were the RPM workflows integrated into the centralized nurse workflow? What were the incentives at the individual and system level for active management, and how well did these additional RPM workflows align with established care responsibilities? These operational factors need to be carefully measured wh -Abstract Truncated-
medicine, general & internal